Regulatory Impact Statement: Allowing sales of cold medicines containing pseudoephedrine
Current
Friday, 12 January 2024
Tuesday, 12 March 2024
Ministry of Health
Legislation
© Crown Copyright, Attribution 4.0 International (CC BY 4.0)
Health
- Legislation: Misuse of Drugs Act 1975, Misuse of Drugs Regulations 1977
- Ministerial portfolio: Health
- Document on Ministry of Health website at March 2024: Regulatory Impact Statement: Allowing sales of cold medicines containing pseudoephedrine
- Assessment: Other - The requirement for quality assurance of RISs has been suspended for decisions relating to 100-Day Plan proposals taken within the 100 Days.
Disclaimer
It is not always possible to provide a fully accessible version of these documents on our website. If you would like a copy of this document in an alternate format, contact the authoring agency directly to make a request.
Some information in these documents may not be appropriate to release publicly and, when requested, will be withheld under the Official Information Act 1982. Where information has been withheld, no public interest has been identified that outweighs the reasons for withholding it.